Srikripa Devarakonda
Stock Analyst at Truist Securities
(4.2)
Main Sectors:
Top Industries:
19 Stocks
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
KYMR Kymera Therapeutics | Maintains: Strong Buy | 53 68 | 57.9 | 17.44% | 4 | Sep 30, 2025 | |
REGN Regeneron Pharmaceut... | Maintains: Buy | 940 812 | 600 | 35.33% | 8 | Aug 11, 2025 | |
INCY Incyte | Maintains: Hold | 73 79 | 86.85 | -9.04% | 11 | Jul 30, 2025 | |
ARVN Arvinas | Downgrades: Hold | 21 11 | 9.61 | 14.46% | 1 | May 5, 2025 | |
BIIB Biogen | Maintains: Buy | 210 199 | 159.88 | 24.47% | 4 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 43 25 | 15.94 | 56.84% | 5 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 60 76 | 64.83 | 17.23% | 2 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 1029 1038 | 840.01 | 23.57% | 4 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 211 217 | 233.87 | -7.21% | 3 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 36 32 | 27.36 | 16.96% | 1 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 33 50 | 15.65 | 219.49% | 6 | Nov 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 36 45 | 37.47 | 20.1% | 4 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 54 54 | 2.15 | 2411.63% | 1 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 18 15 | 8.7 | 72.41% | 7 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 36 | 9.38 | 283.8% | 1 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 86 70 | 56.97 | 22.87% | 4 | May 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 80 60 | n/a | n/a | 2 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 38 | n/a | n/a | 3 | Mar 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 50 34 | n/a | n/a | 2 | Jun 3, 2021 |